Press Ganey Holdings, Inc. (NYSE:PGND) today announced the completion of its acquisition by EQT Equity fund EQT VII (“EQT”), part of the global private equity group EQT. Under the terms of...
Research and Data Reveal Key Quality Metrics to Help Advance Overall Performance In a white paper released today, Press Ganey Holdings, Inc. (NYSE:PGND) identifies the top ten metrics to...
Provides Nursing Leaders a Comprehensive, Single-Source View of Data to Efficiently Target Improvement Strategies and Help Achieve Nursing Excellence Press Ganey Holdings, Inc...
Exclusive collaboration provides Press Ganey clients access to Cleveland Clinic’s foundational communication model Press Ganey Holdings, Inc. (NYSE: PGND) is collaborating with Cleveland...
Press Ganey Holdings, Inc. (NYSE:PGND) today announced the expiration of the 40-day “go shop” period under the terms of the previously announced definitive agreement (the “Merger Agreement”...
Segmentation Helps Enable Organizations to Understand, Prioritize and Meet Patient Needs In a report released today, Press Ganey Holdings, Inc. (NYSE:PGND) identifies unique opportunities...
PRESS GANEY SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Press Ganey Holdings, Inc. (PGND) Over the Proposed Sale of the Company to EQT Faruqi & Faruqi, LLP, a...
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Press Ganey Holdings, Inc. (“Press Ganey”) (NYSE: PGND) stock prior to...
Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against...
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales